Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Drug:  gp100:280-288(288V) peptide vaccine
Find trials that include:  Any drugs shown
Results 1-1 of 1 for your search:
Start Over
Nivolumab, Vaccine Therapy, and Ipilimumab in Treating Patients with Stage III or Stage IV Melanoma That Has Been Removed by Surgery
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 16 and over
Trial IDs: MCC-15651, NCI-2011-00737, CDR0000682183, NCI-P8316, P-8316, 8316, NCT01176474
Start Over